-
DAC for EGA study: Multi-omic analyses from a randomized phase II study of epigenetic priming followed by nivolumab in previously treated metastatic non-small cell lung cancer
Dac
EGAC50000000563
-
Genomewide Association Study of Inflammatory Bowel Disease
Study
EGAS00000000006
-
WTCCC case-control study for Rheumatoid Arthritis
Study
EGAS00000000011
-
WTCCC case-control study for Type 1 Diabetes
Study
EGAS00000000014
-
WTCCC case-control study for Type 2 Diabetes
Study
EGAS00000000016
-
WTCCC case-control study for Coronary Artery Disease
Study
EGAS00000000003
-
Saliva Microbiota of Finnish children from the PANIC study
Study
EGAS50000000708
-
Chromatin_Profiling_in_Twins
Study
EGAS00001000098
-
TB-DAR Whole Genome Sequencing Study
Study
EGAS00001005850
-
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be Heart Health Study (nuMoM2b Heart Health Study)
Study
phs002808